1. Home
  2. KELYB vs KROS Comparison

KELYB vs KROS Comparison

Compare KELYB & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc. Class B

KELYB

Kelly Services Inc. Class B

HOLD

Current Price

$15.18

Market Cap

513.9M

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$11.33

Market Cap

584.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KELYB
KROS
Founded
1946
2015
Country
United States
United States
Employees
5570
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
513.9M
584.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KELYB
KROS
Price
$15.18
$11.33
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$22.25
AVG Volume (30 Days)
86.9K
301.4K
Earning Date
01-01-0001
06-05-2026
Dividend Yield
1.98%
N/A
EPS Growth
N/A
146.00
EPS
N/A
2.30
Revenue
N/A
$243,864,000.00
Revenue This Year
$0.72
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$5.09
Revenue Growth
N/A
N/A
52 Week Low
$8.38
$9.12
52 Week High
$125.00
$22.55

Technical Indicators

Market Signals
Indicator
KELYB
KROS
Relative Strength Index (RSI) 50.50 15.63
Support Level $11.79 N/A
Resistance Level $18.66 $15.21
Average True Range (ATR) 1.39 0.69
MACD -0.22 -0.38
Stochastic Oscillator 54.21 8.53

Price Performance

Historical Comparison
KELYB
KROS

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services to a diverse group of clients operating in the Americas, Europe, and the Asia-Pacific region across various industries. The company's reportable segments are: Enterprise Talent Management, Science, Engineering and Technology, and Education. Maximum revenue is generated from its Enterprise Talent Management segment, which delivers temporary staffing, outcome-based, and permanent placement services focused on light industrial, contact center, and office and clerical specialties in North America across various industries. It also provides talent supply chain and workforce talent solutions, including MSP, RPO, and PPO solutions to its clients. Geographically, it derives key revenue from the USA.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: